NEDD8 and head and neck squamous cell carcinoma: Head and neck tumors were found to significantly overexpress NEDD8 when compared to normal adjacent tissue (p = 0.0076), thus establishing the rationale for exploring targeted inhibition of NEDDylation as an approach for HNSCC therapy.